(Q40907953)

24 September 2017

1 reference

title

Current issues in the use of theophylline (English)

1 reference

24 September 2017

Milgrom H

1

1 reference

24 September 2017

Bender B

series ordinal

2

1 reference

24 September 2017

publication date

1 June 1993

1 reference

The American Review of Respiratory Disease

24 September 2017

published in

1 reference

24 September 2017

volume

147

1 reference

24 September 2017

issue

6 Pt 2

1 reference

24 September 2017

page(s)

S33-9

1 reference

On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Therapeutic effect and dosing strategies for theophylline in the treatment of chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Management of asthma and chronic airflow limitation: are methylxanthines obsolete?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Two distinct adenosine-sensitive sites on adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Direct stimulant effect of aminophylline on catecholamine release from the adrenal medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Increase in plasma free fatty acids and natriuresis by xanthines may reflect adenosine antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Influence of tracheal contraction on relaxant effects in vitro of theophylline and isoprenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Treatment of acute asthma. Is combination therapy with sympathomimetics and methylxanthines indicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Emergency room of treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Relationship of serum theophylline concentrations to histamine-induced bronchospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

The effect of theophylline and enprofylline on allergen-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Inflammatory mechanisms and nocturnal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Airways inflammation in nocturnal asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

New aspects of the therapeutic potential of theophylline in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Regulation of the human IgE antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

The eosinophil and the pathophysiology of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Theophylline toxicity: clinical features of 116 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Evaluation of theophylline overdoses and toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Theophylline and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Psychological change associated with theophylline treatment of asthmatic children: a 6-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Learning and behaviour problems associated with theophylline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Extrapulmonary effects of maintenance therapy with theophylline and inhaled albuterol in patients with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Cognitive and behavioral findings in children taking theophylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

Effects of theophylline on learning and behavior: reason for concern or concern without reason?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_2.S33

10.1164/AJRCCM/147.6_PT_2.S33

21 January 2018

Identifiers

DOI

0 references

1 reference